FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eivind Hovig

Research Profile

Devices

Oligonucleotide Array Sequence Analysis

Procedures

Chemicals & Drugs

Disorders

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Morten Mattingsdal; Ingrid Melle; Andres Server; Ida Elken Sønderby; Andrew Anand Brown; Srdjan Djurovic; Eivind Hovig; Jimmy Jensen; Ingrid Agartz; Ole A Andreassen
Pathway analysis of genetic markers associated with a functional MRI faces paradigm implicates polymorphisms in calcium responsive pathways.
Sigurd Leinæs Bøe; Jens Andreas Lindin Jørgensen; Timothy Lavelle; Ane Sager Longva; Stein Saebøe-Larssen; Eivind Hovig
Light-controlled modulation of gene expression using polyamidoamine formulations.
Jens Andreas Lindin Jørgensen; Ane Sager Longva; Eivind Hovig; Sigurd Leinæs Bøe
Evaluation of biodegradable peptide carriers for light-directed targeting.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eivind Hovig (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Morten Mattingsdal; Ingrid Melle; Andres Server; Ida Elken Sønderby; Andrew Anand Brown; Srdjan Djurovic; Eivind Hovig; Jimmy Jensen; Ingrid Agartz; Ole A Andreassen
Pathway analysis of genetic markers associated with a functional MRI faces paradigm implicates polymorphisms in calcium responsive pathways.
NeuroImage 2013;70():143-9.
2013: Sigurd Leinæs Bøe; Jens Andreas Lindin Jørgensen; Timothy Lavelle; Ane Sager Longva; Stein Saebøe-Larssen; Eivind Hovig
Light-controlled modulation of gene expression using polyamidoamine formulations.
Nucleic acid therapeutics 2013;23(2):160-5.
2013: Jens Andreas Lindin Jørgensen; Ane Sager Longva; Eivind Hovig; Sigurd Leinæs Bøe
Evaluation of biodegradable peptide carriers for light-directed targeting.
Nucleic acid therapeutics 2013;23(2):131-9.
2013: Sigurd Leinæs Bøe; Eivind Hovig
Light-induced mRNA transfection.
Methods in molecular biology (Clifton, N.J.) 2013;969():89-100.
2012: Sigve Nakken; Ole Petter Berge; Julien Fillebeen; Tor-Kristian Jenssen; Morten Johansen; Harald Kirkerød; Eivind Hovig
CellLineMiner: a knowledge portal for human cell lines.
Bioinformation 2012;8(22):1119-22.
2012: Stine H Kresse; Knut Liestøl; Ana H Barragan-Polania; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn; Eivind Hovig; Ola Myklebost; Heidi Maria Namløs; Halfdan Rydbeck; Massimo Serra; Magne Skårn; Leonardo A. Meza-Zepeda
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
PloS one 2012;7(11):e48262.
2012: Fang Liu; Tor-Kristian Jenssen; Winston Kuo; Eivind Hovig
Performance comparison of multiple microarray platforms for gene expression profiling.
Methods in molecular biology (Clifton, N.J.) 2012;802():141-55.
2011: Sigurd L Bøe; Ane Sager Longva; Eivind Hovig
A novel photosensitizer for light-controlled gene silencing.
Nucleic acid therapeutics 2011;21(5):359-67.
2011: Sveinung Gundersen; Eivind Hovig; Matúš Kalaš; Osman Abul; Arnoldo Frigessi; Geir Kjetil Sandve
Identifying elemental genomic track types and representing them uniformly.
BMC bioinformatics 2011;12():494.
2011: Geir Olav Hjortland; Hanne Hoifodt; Knut H Hole; Leonardo A. Meza-Zepeda; Ola Myklebost; Anne Hansen Ree; Sigbjørn Smeland; Siri Tveito; Klaus Beiske; Per J Bohler; Oystein Fodstad; Eivind Hovig
Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
BMC cancer 2011;11():455.
2011: Sigurd Bøe; Birgit Ø Engesaeter; Lina Prasmickaite; Eivind Hovig
Light-directed delivery of nucleic acids.
Methods in molecular biology (Clifton, N.J.) 2011;764():107-21.
2011: Geir K Sandve; Eivind Tøstesen; Morten Johansen; Knut Liestøl; Vigdis Nygaard; Halfdan Rydbeck; Trevor Clancy; Finn Drabløs; Egil Ferkingstad; Arnoldo Frigessi; Ingrid K Glad; Sveinung Gundersen; Lars Holden; Marit Holden; Eivind Hovig
The differential disease regulome.
BMC genomics 2011;12():353.
2011: Trevor Clancy; Marco Pedicini; Filippo Castiglione; Daniele Santoni; Vegard Nygaard; Timothy J Lavelle; Mikael Benson; Eivind Hovig
Immunological network signatures of cancer progression and survival.
BMC medical genomics 2011;4():28.
2010: Sigve Nakken; Einar A Rødland; Eivind Hovig
Impact of DNA physical properties on local sequence bias of human mutation.
Human mutation 2010;31(12):1316-25.
2010: Sigurd Leinaes Bøe; Ane Sager Longva; Eivind Hovig
Cyclodextrin-containing polymer delivery system for light-directed siRNA gene silencing.
Oligonucleotides 2010;20(4):175-82.
2010: Sigurd Bøe; Stein Saebøe-Larssen; Eivind Hovig
Light-induced gene expression using messenger RNA molecules.
Oligonucleotides 2010;20(1):1-6.
2010: Geir K Sandve; Sveinung Gundersen; Halfdan Rydbeck; Ingrid K Glad; Lars Holden; Marit Holden; Knut Liestøl; Trevor Clancy; Egil Ferkingstad; Morten Johansen; Vegard Nygaard; Eivind Tøstesen; Arnoldo Frigessi; Eivind Hovig
The Genomic HyperBrowser: inferential genomics at the sequence level.
Genome biology 2010;11(12):R121.
2009: Gustav Lehne; Unn-Hilde Grasmo-Wendler; Jeanne-Marie Berner; Leonardo A. Meza-Zepeda; Birgitte Lid Adamsen; Aksel Flack; Andrew Reiner; Ole Petter Fraas Clausen; Eivind Hovig; Ola Myklebost
Upregulation of stem cell genes in multidrug resistant K562 leukemia cells.
Leukemia research 2009;33(10):1379-85.
2009: Lina Cekaite; Eivind Hovig; Mouldy Sioud
Monitoring B cell response to immunoselected phage-displayed peptides by microarrays.
Methods in molecular biology (Clifton, N.J.) 2009;524():273-85.
2009: Vigdis Nygaard; Eivind Hovig
Methods for quantitation of gene expression.
Frontiers in bioscience : a journal and virtual library 2009;14():552-69.
2008: Kjetil Boye; Ida Grotterød; Hans-Christian Aasheim; Eivind Hovig; Gunhild M Maelandsmo
Activation of NF-kappaB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes.
International journal of cancer. Journal international du cancer 2008;123(6):1301-10.
2008: Sigurd Boe; Ane S Longva; Eivind Hovig
Evaluation of various polyethylenimine formulations for light-controlled gene silencing using small interfering RNA molecules.
Oligonucleotides 2008;18(2):123-32.
2008: Irene Kraus; Corina Driesch; Svetlana Vinokurova; Eivind Hovig; Achim Schneider; Magnus von Knebel Doeberitz; Matthias Dürst
The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes.
Cancer research 2008;68(7):2514-22.
2008: Vigdis Nygaard; Eivind Hovig
Cell sampling and global nucleic acid amplification.
SEB experimental biology series 2008;61():17-36.
2008: Vigdis Nygaard; Fang Liu; Marit Holden; Winston Kuo; Jeffrey M Trimarchi; Lucila Ohno-Machado; Connie L Cepko; Arnoldo Frigessi; Ingrid K Glad; Mark A van de Wiel; Eivind Hovig; Heidi Lyng
Validation of oligoarrays for quantitative exploration of the transcriptome.
BMC genomics 2008;9():258.
2008: Heidi Lyng; Malin Lando; Runar S Brøvig; Debbie H Svendsrud; Morten Johansen; Eivind Galteland; Odd T Brustugun; Leonardo A. Meza-Zepeda; Ola Myklebost; Gunnar Kristensen; Eivind Hovig; Trond Stokke
GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data.
Genome biology 2008;9(5):R86.
2007: Pål Møller; Anne I Hagen; Jaran Apold; Lovise Maehle; Neal Clark; Bent Fiane; Kjell Løvslett; Eivind Hovig; Anita Vabø
Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.
European journal of cancer (Oxford, England : 1990) 2007;43(11):1713-7.
2007: Fang Liu; Eivind Tøstesen; Jostein K Sundet; Tor-Kristian Jenssen; Christoph Bock; Geir Ivar Jerstad; William G Thilly; Eivind Hovig
The human genomic melting map.
PLoS computational biology 2007;3(5):e93.
2007: Lina Cekaite; Gro Furset; Eivind Hovig; Mouldy Sioud
Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects.
Journal of molecular biology 2007;365(1):90-108.
2007: Lina Cekaite; Qian Peng; Andrew Reiner; Susan Shahzidi; Siri Tveito; Ingegerd Eggen Furre; Eivind Hovig
Mapping of oxidative stress responses of human tumor cells following photodynamic therapy using hexaminolevulinate.
BMC genomics 2007;8():273.
2007: S Bøe; A S Longva; Eivind Hovig
Photochemically induced gene silencing using small interfering RNA molecules in combination with lipid carriers.
Oligonucleotides 2007;17(2):166-73.
2007: Fang Liu; Winston Kuo; Jeffrey M Trimarchi; Claudio Punzo; Connie L Cepko; Lucila Ohno-Machado; Eivind Hovig; Winston Patrick Kuo
Comparison of hybridization-based and sequencing-based gene expression technologies on biological replicates.
BMC genomics 2007;8():153.
2007: Lina Cekaite; Eivind Hovig; Mouldy Sioud
Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses.
Methods in molecular biology (Clifton, N.J.) 2007;360():335-48.
2006: Lina Prasmickaite; Lina Cekaite; Marit Hellum; Eivind Hovig; Anders Høgset; Kristian Berg
Transcriptome changes in a colon adenocarcinoma cell line in response to photochemical treatment as used in photochemical internalisation (PCI).
FEBS letters 2006;580(24):5739-46.
2006: Astrid Stormorken; Karen-Marie Heintz; Per Arne Andresen; Eivind Hovig; Pål Møller
MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer.
Hereditary cancer in clinical practice 2006;4(2):90-3.
2006: S Bøe; Eivind Hovig
Photochemically induced gene silencing using PNA-peptide conjugates.
Oligonucleotides 2006;16(2):145-57.
2006: Vigdis Nygaard; Eivind Hovig
Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling.
Nucleic acids research 2006;34(3):996-1014.
2005: Heidi Lyng; Kirsti Solberg Landsverk; Elin Kristiansen; Paula M DeAngelis; Anne Hansen Ree; Ola Myklebost; Eivind Hovig; Trond Stokke
Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype.
International journal of cancer. Journal international du cancer 2005;115(6):935-42.
2005: Eivind Tøstesen; Geir Ivar Jerstad; Eivind Hovig
Stitchprofiles.uio.no: analysis of partly melted DNA conformations using stitch profiles.
Nucleic acids research 2005;33(Web Server issue):W573-6.
2005: Anja Gulliksen; Lars Anders Solli; Klaus Drese; Olaf Sörensen; Frank Karlsen; Henrik Rogne; Eivind Hovig; Reidun Sirevåg
Parallel nanoliter detection of cancer markers using polymer microchips.
Lab on a chip 2005;5(4):416-20.
2005: Tor-Kristian Jenssen; Eivind Hovig
Gene-expression profiling in breast cancer.
Lancet 2005;365(9460):634-5.
2005: Vigdis Nygaard; Marit Holden; Anders Løland; Mette Langaas; Ola Myklebost; Eivind Hovig
Limitations of mRNA amplification from small-size cell samples.
BMC genomics 2005;6():147.
2004: Tone Bjørge; A K Lie; Eivind Hovig; Randi Gislefoss; Svein Hansen; Egil Jellum; H Langseth; Kjell Nustad; Claes G Tropé; Anne Dørum
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.
British journal of cancer 2004;91(10):1829-34.
2004: Gunhild Trøen; Vigdis Nygaard; Tor-Kristian Jenssen; Ida Münster Ikonomou; Anne Tierens; Estella Matutes; Alicja M Gruszka-Westwood; Daniel Catovsky; Ola Myklebost; Grete Fossum Lauritzsen; Eivind Hovig; Jan Delabie
Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
The Journal of molecular diagnostics : JMD 2004;6(4):297-307.
2004: Fang Liu; Tor-Kristian Jenssen; Vigdis Nygaard; John Sack; Eivind Hovig
FigSearch: a figure legend indexing and classification system.
Bioinformatics (Oxford, England) 2004;20(16):2880-2.
2004: Véronique Cruciani; Karen-Marie Heintz; Trine Husøy; Eivind Hovig; David J Warren; Svein-Ole Mikalsen
The detection of hamster connexins: a comparison of expression profiles with wild-type mouse and the cancer-prone Min mouse.
Cell communication & adhesion 2004;11(5-6):155-71.
2004: Lina Cekaite; Ola Haug; Ola Myklebost; Magne Aldrin; Bjørn Østenstad; Marit Holden; Arnoldo Frigessi; Eivind Hovig; Mouldy Sioud
Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method.
Proteomics 2004;4(9):2572-82.
2004: Per O Ekstrøm; Tone Bjørge; Anne Dørum; Ane Sager Longva; Karen-Marie Heintz; David J Warren; Svein Hansen; Randi Gislefoss; Eivind Hovig
Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis.
Analytical chemistry 2004;76(15):4406-9.
2004: Heidi Lyng; Azadeh Badiee; Debbie H Svendsrud; Eivind Hovig; Ola Myklebost; Trond Stokke
Profound influence of microarray scanner characteristics on gene expression ratios: analysis and procedure for correction.
BMC genomics 2004;5(1):10.
2004: Anja Gulliksen; Lars Solli; Frank Karlsen; Henrik Rogne; Eivind Hovig; Trine Nordstrøm; Reidun Sirevåg
Real-time nucleic acid sequence-based amplification in nanoliter volumes.
Analytical chemistry 2004;76(1):9-14.
2003: Junbai Wang; Trond Hellem Bø; Inge Jonassen; Ola Myklebost; Eivind Hovig
Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data.
BMC bioinformatics 2003;4():60.
2003: Junbai Wang; Ola Myklebost; Eivind Hovig
MGraph: graphical models for microarray data analysis.
Bioinformatics (Oxford, England) 2003;19(17):2210-1.
2003: Eivind Tøstesen; Fang Liu; Tor-Kristian Jenssen; Eivind Hovig
Speed-up of DNA melting algorithm with complete nearest neighbor properties.
Biopolymers 2003;70(3):364-76.
2003: Kristin Andersen; Birgitte Smith-Sørensen; Kjetil Boye Pedersen; Eivind Hovig; Ola Myklebost; Øystein Fodstad; Gunhild M Maelandsmo
Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest.
British journal of cancer 2003;88(12):1995-2001.
2003: Vigdis Nygaard; Anders Løland; Marit Holden; Mette Langaas; Håvard Rue; Fang Liu; Ola Myklebost; Øystein Fodstad; Eivind Hovig; Birgitte Smith-Sørensen
Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance.
BMC genomics 2003;4(1):11.
2003: Berit Mathisen; Rune I Lindstad; Janne Hansen; Sara Ann El-Gewely; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.
Clinical & experimental metastasis 2003;20(8):701-11.
2002: Tor-Kristian Jenssen; Eivind Hovig
The semantic web and biology.
Drug discovery today 2002;7(19):992.
2002: Tor-Kristian Jenssen; Winston Kuo; T Stokke; Eivind Hovig
Associations between gene expressions in breast cancer and patient survival.
Human genetics 2002;111(4-5):411-20.
2002: Junbai Wang; Vigdis Nygaard; Birgitte Smith-Sørensen; Eivind Hovig; Ola Myklebost
MArray: analysing single, replicated or reversed microarray experiments.
Bioinformatics (Oxford, England) 2002;18(8):1139-40.
2002: Tor-Kristian Jenssen; Mette Langaas; Winston Kuo; Birgitte Smith-Sørensen; Ola Myklebost; Eivind Hovig
Analysis of repeatability in spotted cDNA microarrays.
Nucleic acids research 2002;30(14):3235-44.
2002: Anne Hansen Ree; Olav Engebraaten; Eivind Hovig; Øystein Fodstad
Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: gene expression profiles in bone marrow target cells.
International journal of cancer. Journal international du cancer 2002;97(1):28-33.
2001: Pål Møller; Ketil Heimdal; Jaran Apold; A Fredriksen; Ake Borg; Eivind Hovig; Anne I Hagen; Bjørn Hagen; J C Pedersen; Lovise Maehle
Genetic epidemiology of BRCA1 mutations in Norway.
European journal of cancer (Oxford, England : 1990) 2001;37(18):2428-34.
2001: Eivind Hovig; Phil D Rye; David J Warren; Kjell Nustad
CA 125: the end of the beginning.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(6):345-7.
2001: Anne-Lise Børresen-Dale; Eivind Hovig; Birgitte Smith-Sørensen
Detection of mutations by denaturing gradient gel electrophoresis.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2001;Chapter 7():Unit 7.5.
2001: Pål Møller; Ake Borg; Ketil Heimdal; Jaran Apold; J Vallon-Christersson; Eivind Hovig; Lovise Maehle
The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.
European journal of cancer (Oxford, England : 1990) 2001;37(8):1027-32.
2001: Tor-Kristian Jenssen; Astrid Laegreid; Jan Komorowski; Eivind Hovig
A literature network of human genes for high-throughput analysis of gene expression.
Nature genetics 2001;28(1):21-8.
2001: Jan Komorowski; Torgeir R Hvidsten; Tor-Kristian Jenssen; D Tjeldvoll; Eivind Hovig; Astrid Laegreid; Arne K Sandvik
[New knowledge derived from measurement of gene expression with the DNA microarray method].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(10):1229-32.
2001: Eivind Hovig; Gunhild M Maelandsmo; T Mellingsaeter; Oystein Fodstad; S S Mielewczyk; J Wolfe; J Goodchild
Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA.
Antisense & nucleic acid drug development 2001;11(2):67-75.
2001: Eivind Hovig; Ola Myklebost; S Aamdal; Erlend Smeland
[Gene therapy in cancer].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(4):482-8.
1999: Ake Borg; Anne Dørum; Ketil Heimdal; Lovise Maehle; Eivind Hovig; Pål Møller
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
Disease markers 1999;15(1-3):79-84.
1999: Kristin Bjørnland; Jan-Olof Winberg; O T Odegaard; Eivind Hovig; Thrina Loennechen; Ansgar O Aasen; Oystein Fodstad; Gunhild M Maelandsmo
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Cancer research 1999;59(18):4702-8.
1999: Anne Hansen Ree; M Tvermyr; Olav Engebraaten; M Rooman; Oystein Røsok; Eivind Hovig; Leonardo A. Meza-Zepeda; Oyvind S Bruland; Oystein Fodstad
Expression of a novel factor in human breast cancer cells with metastatic potential.
Cancer research 1999;59(18):4675-80.
1999: Anne Dørum; Ketil Heimdal; Eivind Hovig; M Inganäs; Pål Møller
Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer.
American journal of human genetics 1999;65(3):671-9.
1999: Anne Dørum; Eivind Hovig; Claes Tropé; M Inganas; Pål Møller
Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA.
European journal of cancer (Oxford, England : 1990) 1999;35(5):779-81.
1999: P Ruud; Oystein Fodstad; Eivind Hovig
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells.
International journal of cancer. Journal international du cancer 1999;80(1):119-25.
1998: Lina Prasmickaite; A Hogset; Gunhild M Maelandsmo; Kristian Berg; J Goodchild; T Perkins; Oystein Fodstad; Eivind Hovig
Intracellular metabolism of a 2'-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis.
Nucleic acids research 1998;26(18):4241-8.
1998: K Andersen; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL.
Anticancer research 1998;18(5A):3299-303.
1997: Anne Dørum; Pål Møller; E J Kamsteeg; Hans Scheffer; M Burton; Ketil Heimdal; Lovise Maehle; Eivind Hovig; Claes G Tropé; Annemarie H Van Der Hout; MA van der Meulen; Charles H C M Buys; Gerard te Meerman
A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2390-2.
1997: Gunhild M Maelandsmo; Vivi Ann Flørenes; T Mellingsaeter; Eivind Hovig; R S Kerbel; Oystein Fodstad
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma.
International journal of cancer. Journal international du cancer 1997;74(4):464-9.
1997: H de Graaf; Gunhild M Maelandsmo; P Ruud; Anne Forus; T Oyjord; Oystein Fodstad; Eivind Hovig
Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2.
International journal of cancer. Journal international du cancer 1997;72(1):191-6.
1996: Gunhild M Maelandsmo; Eivind Hovig; Martina Skrede; Olav Engebraaten; Vivi Ann Flørenes; Ola Myklebost; Mariam Grigorian; Eugene Lukanidin; K J Scanlon; Oystein Fodstad
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.
Cancer research 1996;56(23):5490-8.
1996: Gunhild M Maelandsmo; Vivi Ann Flørenes; Eivind Hovig; T Oyjord; Olav Engebraaten; Ruth Holm; A L Børresen; Oystein Fodstad
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
British journal of cancer 1996;73(8):909-16.
1996: Birgitte Smith-Sørensen; Eivind Hovig
CDKN2A (p16INK4A) somatic and germline mutations.
Human mutation 1996;7(4):294-303.
1996: Monica Hollstein; B Shomer; M Greenblatt; thierry soussi; Eivind Hovig; Roberto Montesano; Curtis C Harris
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation.
Nucleic acids research 1996;24(1):141-6.
1995: Gunhild M Maelandsmo; Jeanne-Marie Berner; Vivi Ann Flørenes; Anne Forus; Eivind Hovig; Oystein Fodstad; Ola Myklebost
Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
British journal of cancer 1995;72(2):393-8.
1995: A H Deggerdal; F Pettersen; Gunnar Kvalheim; E Hornes; Erlend Smeland; Oystein Fodstad; Eivind Hovig
Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
Laboratory investigation; a journal of technical methods and pathology 1995;72(4):411-8.
1994: Monica Hollstein; K Rice; M S Greenblatt; thierry soussi; Rainer Fuchs; Therese Sørlie; Eivind Hovig; Birgitte Smith-Sørensen; Roberto Montesano; Curtis C Harris
Database of p53 gene somatic mutations in human tumors and cell lines.
Nucleic acids research 1994;22(17):3551-5.
1993: Eivind Hovig; E Mullaart; A L Børresen; André G Uitterlinden; Jan Vijg
Genome scanning of human breast carcinomas using micro- and minisatellite core probes.
Genomics 1993;17(1):66-75.
1993: A Andreassen; T Oyjord; Eivind Hovig; Ruth Holm; Vivi Ann Flørenes; Jahn M Nesland; Ola Myklebost; J Høie; Oyvind S Bruland; A L Børresen
p53 abnormalities in different subtypes of human sarcomas.
Cancer research 1993;53(3):468-71.
1992: Eivind Hovig; A Andreassen; B M Fangan; A L Børresen
A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomas.
Cancer genetics and cytogenetics 1992;64(2):178-82.
1992: Eivind Hovig; Birgitte Smith-Sørensen; André G Uitterlinden; A L Børresen
Detection of DNA variation in cancer.
Pharmacogenetics 1992;2(6):317-28.
1992: Eivind Hovig; Birgitte Smith-Sørensen; M C Gebhardt; David Ryberg; Ragnhild A Lothe; A L Børresen
No alterations in exon 21 of the RB1 gene in sarcomas and carcinomas of the breast, colon, and lung.
Genes, chromosomes & cancer 1992;5(2):97-103.
1992: Birgitte Smith-Sørensen; Eivind Hovig; B Andersson; A L Børresen
Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE).
Mutation research 1992;269(1):41-53.
1992: A L Børresen; Tone Ikdal Andersen; Judy E Garber; N Barbier-Piraux; Steinunn Thorlacius; Jorunn E Eyfjörd; L Ottestad; Birgitte Smith-Sørensen; Eivind Hovig; David Malkin
Screening for germ line TP53 mutations in breast cancer patients.
Cancer research 1992;52(11):3234-6.
1991: Eivind Hovig; Ragnhild A Lothe; G Farrants; A Brøgger; Oystein Fodstad; A L Børresen
Chromosome 13 alterations in osteosarcoma cell lines derived from a patient with previous retinoblastoma.
Cancer genetics and cytogenetics 1991;57(1):31-40.
1991: A L Børresen; Eivind Hovig; Birgitte Smith-Sørensen; David Malkin; S Lystad; Tone Ikdal Andersen; Jahn M Nesland; K J Isselbacher; S H Friend
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(19):8405-9.
1991: G C Alfsen; K Beiske; Harald Holte; Eivind Hovig; A Deggerdal; I Sandlie; E Widing; S Slørdahl; L K Klepper; W Sizoo
T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five cases.
Blood 1991;77(9):2023-30.
1991: Eivind Hovig; Birgitte Smith-Sørensen; A Brøgger; A L Børresen
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection.
Mutation research 1991;262(1):63-71.
1990: A L Børresen; Eivind Hovig; Birgitte Smith-Sørensen; H Vrieling; Jaran Apold; A Brøgger
Screening for base mutations in the PAH and HPRT loci using the polymerase chain reaction (PCR) in combination with denaturing gradient gel electrophoresis (DGGE).
Progress in clinical and biological research 1990;340A():389-98.
1989: Sjur Olsnes; Harald Stenmark; S McGill; Eivind Hovig; R. John Collier; Kirsten Sandvig
Formation of active diphtheria toxin in vitro based on ligated fragments of cloned mutant genes.
The Journal of biological chemistry 1989;264(22):12747-51.
1988: A L Børresen; Eivind Hovig; A Brøgger
Detection of base mutations in genomic DNA using denaturing gradient gel electrophoresis (DGGE) followed by transfer and hybridization with gene-specific probes.
Mutation research 1988;202(1):77-83.
1987: Eivind Hovig; Jan-Olof Winberg; Oystein Fodstad; A Brøgger; T Gedde-Dahl
Chromosome 13 instability and esterase D expression in an osteosarcoma cell line.
Cancer genetics and cytogenetics 1987;24(2):327-34.